Elevated TWIST1 Expression in Myelodysplastic Syndromes/acute Myeloid Leukemia Reduces Efficacy of Hypomethylating Therapy with Decitabine
Overview
Authors
Affiliations
Kanwal R, Esposito J, Jawed B, Zakir S, Pulcini R, Martinotti R Cancers (Basel). 2025; 17(3).
PMID: 39941895 PMC: 11817253. DOI: 10.3390/cancers17030529.
O-GlcNAcylated FTO promotes m6A modification of SOX4 to enhance MDS/AML cell proliferation.
Gou J, Bi J, Wang K, Lei L, Feng Y, Tan Z Cell Commun Signal. 2025; 23(1):43.
PMID: 39849461 PMC: 11761745. DOI: 10.1186/s12964-025-02058-6.
Mendes M, Monteiro A, Neto E, Barrias C, Sobrinho-Simoes M, Duarte D Int J Mol Sci. 2024; 25(8).
PMID: 38674015 PMC: 11050723. DOI: 10.3390/ijms25084430.
Wang N, Yin J, You N, Zhu W, Guo N, Liu X Haematologica. 2023; 109(1):84-97.
PMID: 37767575 PMC: 10772510. DOI: 10.3324/haematol.2023.282748.
Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML.
Li H, Wang Y, Feng S, Chang K, Yu X, Yang F Cell Commun Signal. 2023; 21(1):255.
PMID: 37736724 PMC: 10514931. DOI: 10.1186/s12964-023-01278-y.